{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:45:16Z","timestamp":1770414316650,"version":"3.49.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Postgraduate Medicine"],"published-print":{"date-parts":[[2017,11,17]]},"DOI":"10.1080\/00325481.2017.1387473","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T15:05:54Z","timestamp":1509375954000},"page":"849-857","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Albiglutide efficacy and safety in the Latino\/Hispanic subpopulation for the integrated phase III program"],"prefix":"10.1080","volume":"129","author":[{"given":"Jaime A.","family":"Davidson","sequence":"first","affiliation":[{"name":"Touchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Jones-Leone","sequence":"additional","affiliation":[{"name":"Medical Affairs, GlaxoSmithKline, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy H.","family":"Wilson","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Research Triangle Park, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nino","sequence":"additional","affiliation":[{"name":"Research and Development, GlaxoSmithKline, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Forero-Schwanhaeuser","sequence":"additional","affiliation":[{"name":"Medical Affairs, GlaxoSmithKline, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rickey R.","family":"Reinhardt","sequence":"additional","affiliation":[{"name":"Research and Development, GlaxoSmithKline, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"CIT0001","unstructured":"Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2017. Atlanta (GA): U.S. Department of Health and Human Services; 2017. Available from: https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf"},{"key":"CIT0002","unstructured":"Centers for Disease Control and Prevention. At a glance 2016. Diabetes: working to reverse the epidemic. Atlanta (GA): U.S. Department of Health and Human Services; 2016. Available from: https:\/\/www.cdc.gov\/chronicdisease\/resources\/publications\/aag\/pdf\/2016\/diabetes-aag.pdf"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2939"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.2.102"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.90.8.1288"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0382"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E685"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1029894"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.2337\/cd15-0048"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9744-6"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.01.004"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1518"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0366"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2010.035.09.1516042"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12382"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3795-1"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0024"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3360-3"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0001"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70214-6"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12414"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2855"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2012.03006.x"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0188"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12679"},{"key":"CIT0026","unstructured":"BYETTA\u00ae (exenatide) Injection [prescribing information]. Wilmington (DE): AstraZeneca Pharmaceuticals LP; 2015. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021773s040lbl.pdf"},{"key":"CIT0027","unstructured":"BYDUREON\u2122 (exenatide extended-release) for injectable suspension [prescribing information]. Wilmington (DE): AstraZeneca Pharmaceuticals LP; 2015. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022200s015s016s017s018lbl.pdf"},{"key":"CIT0028","unstructured":"VICTOZA\u00ae (liraglutide) injection, for subcutaneous use [prescribing information]. Bagsvaerd (Denmark): Novo Nordisk A\/S; 2016. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/022341s025lbl.pdf"}],"container-title":["Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00325481.2017.1387473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T01:42:00Z","timestamp":1597542120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00325481.2017.1387473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,11,17]]}},"alternative-id":["10.1080\/00325481.2017.1387473"],"URL":"https:\/\/doi.org\/10.1080\/00325481.2017.1387473","relation":{},"ISSN":["0032-5481","1941-9260"],"issn-type":[{"value":"0032-5481","type":"print"},{"value":"1941-9260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}